Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 24, 2026
Why Is Digital Currency X Technology (DCX) Stock Down -25.34% Today?

Why Is Digital Currency X Technology (DCX) Stock Down -25.34% Today?

Key Takeaways

  • DCX shares tumbled roughly 25.34% in Thursday's session, extending a multi-day collapse.
  • The primary catalyst was the company's announcement of a 160-for-1 reverse stock split set to take effect September 28 to restore Nasdaq listing compliance.
  • Secondary pressure came from dilution concerns tied to recently issued warrants with anti-dilution price-adjustment provisions.
  • The decline unfolded amid broader weakness in speculative, small-cap Chinese ADRs.
  • Traders are watching the September 28 split effective date and any updates on Nasdaq bid-price compliance.

Opening Summary

Digital Currency X Technology Inc. (DCX), the Hong Kong-based digital-asset treasury company formerly known as Chijet Motor, saw its shares plunge on Thursday. The stock dropped approximately 25.34% to around $0.0548, down from a prior close of $0.0734. The selloff followed the company's announcement of a sweeping reverse stock split, a move markets interpreted as a sign of continued distress at the micro-cap issuer as it struggles to maintain its Nasdaq listing.

Reverse Stock Split Announcement Sparks Selling

The dominant driver behind the move was a corporate announcement revealing a 160-for-1 reverse stock split of the company's Class A and Class B ordinary shares, scheduled to take effect on September 28. The company framed the consolidation as a measure to regain compliance with Nasdaq's minimum bid price requirement, a recurring challenge for DCX as its share price has eroded dramatically over the past year.

Reverse splits are frequently read by investors as a red flag, signaling that a company has been unable to support its share price through operating performance. The announcement immediately revived concerns about the company's long-term viability, prompting heavy selling pressure in Thursday's session. Under the plan, the company's roughly 375 million Class A shares would be reduced to approximately 2.3 million shares, mechanically lifting the per-share price without changing the underlying enterprise value.

Dilution and Capital-Structure Worries Compound the Decline

Beyond the split itself, investors focused on the structure of the company's recent financing activity. The company recently closed a registered direct offering and had earlier announced a private placement of up to $700 million in units, each consisting of one Class A ordinary share and warrants. Critically, certain Series A and Series B warrants issued in connection with these transactions carry anti-dilution provisions that adjust the exercise price based on volume-weighted average price (VWAP) lows.

As the share price falls, these provisions can trigger further downward adjustment of warrant exercise prices, creating a feedback loop of additional dilution risk for existing shareholders. This overhang, combined with the announced reverse split, gave traders multiple reasons to exit positions on Thursday.

Market Context and Trading Activity

The selloff in DCX did not occur in isolation. The stock is down sharply over the trailing week, falling from roughly $0.44 on September 17 to its current levels, a decline of more than 85%. Thursday's move also coincided with broad-based weakness across speculative, small-cap Chinese ADRs, several of which posted double-digit percentage declines in the same session.

Trading volume remained elevated relative to the company's recent average, consistent with heightened distribution and a continued exodus of speculative interest. Technical indicators pointed to deeply oversold conditions, with the stock trading far below its 50-day and 200-day moving averages, though oversold readings have provided little support during the stock's prolonged downtrend.

What Comes Next for DCX

Investors will closely monitor the September 28 effective date of the reverse split and the subsequent behavior of the adjusted share price. The company's ability to remain listed on the Nasdaq Capital Market remains a central question, as does its progress executing a strategic pivot away from legacy electric-vehicle manufacturing toward digital-asset treasury management. The company has already divested its loss-making EV subsidiary, Chijet Inc., for a nominal sum as part of that transition.

Key uncertainties include the extent of future dilution from outstanding warrants and convertible securities, the company's ability to deploy its digital-asset holdings profitably, and broader sentiment toward speculative Chinese-listed companies. Until the company demonstrates sustained operational traction, volatility is likely to remain elevated.

Trending AI Robots

For traders seeking a more systematic approach to navigating volatile names like DCX, Tickeron's Trending AI Robots page offers a curated view of its strongest-performing AI trading bots. Tickeron provides hundreds of AI-driven trading bots covering thousands of tickers, but only those demonstrating the strongest results under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing investors to explore automated approaches tailored to their objectives. Explore the Trending AI Robots page to see which strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: DCX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


DCX's Stochastic Oscillator is staying in oversold zone for 18 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

DCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DCX as a result. In 48 of 49 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for DCX turned negative on August 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 22 similar instances when the indicator turned negative. In 22 of the 22 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DCX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for DCX entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.127) is normal, around the industry mean (8.822). P/E Ratio (0.001) is within average values for comparable stocks, (495.066). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.483). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (0.101) is also within normal values, averaging (2.589).

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. DCX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DCX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are Tesla (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), NIO Inc. (NYSE:NIO).

Industry description

Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.

Market Cap

The average market capitalization across the Motor Vehicles Industry is 72.67B. The market cap for tickers in the group ranges from 1.86K to 1.48T. TSLA holds the highest valuation in this group at 1.48T. The lowest valued company is ZAPPF at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Motor Vehicles Industry was -8%. For the same Industry, the average monthly price growth was -15%, and the average quarterly price growth was -21%. LOBO experienced the highest price growth at 11%, while DCX experienced the biggest fall at -77%.

Volume

The average weekly volume growth across all stocks in the Motor Vehicles Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was -29% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 60
Price Growth Rating: 69
SMR Rating: 86
Profit Risk Rating: 91
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
DCX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MotorVehicles

Industry
N/A
Address
Capital Centre, 151 Gloucester Road
Phone
+852 4492766221
Employees
75
Web
N/A
Interact to see
Advertisement
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
Why Is Digital Currency X Technology (DCX) Stock Down -25.34% Today?